Skip to main content
OPRX logo

OptimizeRx Corporation

OPRXNASDAQHealthcareHealth Information Services

$8.51Today:- (-)1Y −54.73%

As of Oct 16, 2026 close

Market cap
$166.25M
P/E (TTM)
36.13
Forward P/E
-
Dividend yield
-
52-week range
$4.54$22.25
Volume (live)
-
Avg. volume (3M)
156.41K

OptimizeRx Corporation (OPRX) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for OptimizeRx Corporation stock.

Analyst Consensus Rating

Investment consensus from 6 professional research analysts

Consensus Rating

Buy
Based on 6 unique analysts
Medium Confidence5.0:1 Buy/Sell

Average Price Target

$13.00
+52.76% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest OPRX Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Ryan Daniels
William Blair
BuyMaintains
-
Josh Nichols
B Riley
BuyMaintains
$10.00 → $11.00
Shreya Majumder
Zacks Equity Research
SellInitiates Coverage
-
David Grossman
Stifel Nicolaus
BuyMaintains
$14.00 → $12.00
Eric Martinuzzi
Lake Street
BuyMaintains
$11.00
Richard Baldry
Roth MKM
BuyMaintains
$18.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 2, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for OPRX?

The analyst consensus rating for OPRX is Buy, based on the latest ratings from 6 analysts over the last 90 days.

What is the average price target for OPRX?

The average 12-month price target for OPRX is $13.00, representing an upside of 52.8% from the Oct 16, 2026 close of $8.51.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.